← Back to Clinical Trials
Recruiting Phase 4 NCT06819436

NCT06819436 Effect of Dexamethasone on Post-spinal Hypotension

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06819436
Status Recruiting
Phase Phase 4
Sponsor Shaheed Mohtarma Benazir Bhutto Institue of Trauma
Condition Post Spinal Anaesthesia Hypotension
Study Type INTERVENTIONAL
Enrollment 170 participants
Start Date 2025-02
Primary Completion 2025-04

Trial Parameters

Condition Post Spinal Anaesthesia Hypotension
Sponsor Shaheed Mohtarma Benazir Bhutto Institue of Trauma
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 170
Sex ALL
Min Age 65 Years
Max Age 85 Years
Start Date 2025-02
Completion 2025-04
Interventions
DexamethasonePlacebo

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to learn if intravenous dexamethasone is effective for prevention of post spinal hypotension in geriatric population undergoing orthopedic surgeries. The main question aim to answer is: Does intravenous dexamethasone in participants undergoing orthopedic procedures of lower limb under spinal anesthesia prevents post spinal hypotension? Researchers are comparing two groups of participants * Participants in (Dexamethasone Group) Group D are receiving intravenous dexamethasone 8mg preoperatively * Participants in (Placebo Group) Group P are receiving placebo preoperatively.

Eligibility Criteria

Inclusion Criteria: Patient undergoing orthopedic surgery in spinal anesthesia. ASA ≤ 2. Exclusion Criteria: Patients with history of cardiac arrhythmias. Patients with history of acute coronary syndrome. Patient with history of polytrauma. Patients with contraindication to SA (e.g., coagulopathy, thrombocytopenia, allergy to local anesthetic agent) and those on steroids or serotonin related medications (e.g., selective serotonin reuptake inhibitor) will be excluded.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology